This study identified four drugs with potential therapeutic effects on ALDH1A2 and FZD2, including VANTICTUMAB, RETINOL, HYDROCHLOROTHIAZIDE, and ATENOLOL, which may prove beneficial for treating BD individuals with HF. This evidence concerns the gene FZD2 and Behcet disease.